Adicet Bio Inc. (ACET) is priced at $16.70 after the most recent trading session. At the very opening of the session, the stock price was $14.50 and reached a high price of $17.80, prior to closing the session it reached the value of $13.69. The stock touched a low price of $14.09.
Recently in News on February 10, 2021, Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement. Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the pricing of an underwritten public offering of 9,230,770 shares of its common stock at a public offering price of $13.00 per share. Adicet also granted the underwriters a 30-day option to purchase up to an additional 1,344,743 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $120.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. All of the shares in the offering are to be sold by Adicet. The offering is expected to close on or about February 12, 2021, subject to customary closing conditions. You can read further details here
Adicet Bio Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $17.80 on 02/10/21, with the lowest value was $12.05 for the same time period, recorded on 02/01/21.
Adicet Bio Inc. (ACET) full year performance was 71.63%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Adicet Bio Inc. shares are logging -23.04% during the 52-week period from high price, and 177.41% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.02 and $21.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1565996 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Adicet Bio Inc. (ACET) recorded performance in the market was 18.86%, having the revenues showcasing 51.13% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 324.48M, as it employees total of 18 workers.
Market experts do have their say about Adicet Bio Inc. (ACET)
During the last month, 3 analysts gave the Adicet Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 12.98, with a change in the price was noted +0.59. In a similar fashion, Adicet Bio Inc. posted a movement of +3.66% for the period of last 100 days, recording 111,743 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ACET is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Adicet Bio Inc. (ACET)
Raw Stochastic average of Adicet Bio Inc. in the period of last 50 days is set at 85.16%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 80.87%. In the last 20 days, the company’s Stochastic %K was 64.81% and its Stochastic %D was recorded 47.16%.
Bearing in mind the latest performance of Adicet Bio Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 18.86%. Additionally, trading for the stock in the period of the last six months notably improved by 0.24%, alongside a boost of 71.63% for the period of the last 12 months. The shares increased approximately by 35.00% in the 7-day charts and went up by 21.28% in the period of the last 30 days. Common stock shares were driven by 51.13% during last recorded quarter.